SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-22-005558
Filing Date
2022-08-11
Accepted
2022-08-11 16:15:54
Documents
56
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sonoma_i10q-063022.htm   iXBRL 10-Q 559124
2 CERTIFICATION sonoma_ex3101.htm EX-31 8657
3 CERTIFICATION sonoma_ex3102.htm EX-31.2 8456
4 CERTIFICATION sonoma_ex3201.htm EX-32.1 4571
  Complete submission text file 0001683168-22-005558.txt   3181892

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE snoa-20220630.xsd EX-101.SCH 24369
6 XBRL CALCULATION FILE snoa-20220630_cal.xml EX-101.CAL 47452
7 XBRL DEFINITION FILE snoa-20220630_def.xml EX-101.DEF 90822
8 XBRL LABEL FILE snoa-20220630_lab.xml EX-101.LAB 234340
9 XBRL PRESENTATION FILE snoa-20220630_pre.xml EX-101.PRE 190747
50 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_i10q-063022_htm.xml XML 353989
Mailing Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189
Business Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 221156070
SIC: 2834 Pharmaceutical Preparations